The implementation of a GBS strategy begins with an independent assessment of the pharmaceutical company’s maturity along 10 dimensions that encompass the organization’s operating model. All of these dimensions need to be evaluated from different vantage points to be assessed for their maturity level. For example, tax and risk capabilities may vary widely, depending in which part of the world the company is operating.
Courtesy of KMPG
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.